Log In
BCIQ
Print this Print this
 

maralixibat (SHP625) (formerly LUM001)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionInhibitor of solute carrier family 10 sodium-dependent bile acid transporter member 2 (SLC10A2; ASBT; IBAT)
Molecular Target Solute carrier family 10 sodium-dependent bile acid transporter member 2 (SLC10A2) (ASBT) (IBAT)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$565.3M

$300.3M

$265.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/11/2014

$565.3M

$300.3M

$265.0M

Get a free BioCentury trial today